Predictive Oncology Shares Gain 33% After Ovarian Cancer AI Study
By Matt Walker Predictive Oncology Inc. shares rose 33% after the company said it will present positive results from a study using its artificial intelligence to more accurately predict survival outc
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) fell sharply during Tuesday's session after the company announced the pricing of a $12 million public offering.Applied DNA Sciences shares tumbled 67
Why Predictive Oncology (POAI) Stock Is Skyrocketing
Predictive Oncology Inc (NASDAQ:POAI) shares are trading higher by 46.6% to $2.30 during Tuesday's session after the company announced positive results from a retrospective study conducted with UPMC M
Applied DNA Sciences, Sharps Technology, Akanda Among Healthcare Movers
Predictive Oncology Gains, to Present Positive Results From a Retrospective Study
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersSharps Technology (NASDAQ:STSS) shares rose 193.0% to $0.63 during Tuesday's pre-market session. The market value of their outstanding shares is at $9.8 million. Insmed (NASDAQ:INSM) shares mov
Top Premarket Gainers
Insmed (INSM) shares more than doubled Tuesday premarket after the company said its experimental drug for bronchiectasis lung disease met its primary endpoint in a late-stage study. Calliditas Therape
Express News | Predictive Oncology Shares Are Trading Higher After the Company Announced Results From Its Ovarian Caner Study With UPMC Magee-Womens Hospital
Trending Stocks Today: Sharps Technology Surges 218.05% Pre-Market
May 28th - US stocks trending pre-market: Gainers: $Sharps Technology(STSS.US)$ shoots up 218.05% to $0.68 with a turnover of $30.97 million. $Insmed(INSM.US)$ soars 131.18% to $50.86 with a turnover
Express News | Predictive Oncology Announces Positive Results From Ovarian Cancer Study With Upmc Magee-Womens Hospital to Be Presented at the 2024 American Society of Clinical Oncology (Asco) Annual Meeting
Predictive Oncology Announces Positive Results From Ovarian Cancer Study With UPMC Magee-Womens Hospital to Be Presented at The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Study successfully demonstrated Predictive's ability to build AI multi-omic machine learning models to predict survival outcomes among ovarian cancer patients better than clinical data alonePITTSBURGH
Predictive Oncology Inc (POAI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Earnings Call Summary | Predictive Oncology(POAI.US) Q1 2024 Earnings Conference
The following is a summary of the Predictive Oncology Inc. (POAI) Q1 2024 Earnings Call Transcript:Financial Performance:Predictive Oncology concluded Q1 2024 with $5.2 million cash and $4.0 million i
Express News | Predictive Oncology Inc -Qtrly Shr Loss $1.04
Express News | Predictive Oncology Q1 EPS $(1.04) Compared to $(0.86) YoY, Sales $419.6K Up From $239.9K YoY
Predictive Oncology 1Q Rev $419,646 >POAI
Predictive Oncology 1Q Rev $419,646 >POAI
Press Release: Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update Company to host investor call and webcast today, May 15th, at 8:30am EDT PITTSBURGH, May 15, 2024 (GLOBE
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
Company to host investor call and webcast today, May 15th, at 8:30am EDTPITTSBURGH, May 15, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its propr
Predictive Oncology | 10-Q: Quarterly report
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
PITTSBURGH, May 10, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ:POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive
No Data